A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)
PHASE1CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
July 31, 2006
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
Conditions
HypercholesterolemiaHyperlipidemia
Interventions
DRUG
MK0859
All Listed Sponsors
lead
Merck Sharp & Dohme LLC
INDUSTRY
NCT00565292 - A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) | Biotech Hunter | Biotech Hunter